Oncolytics Biotech Financial Overview
Oncolytics Biotech's market cap is currently $106.86M. The company's EPS TTM is $-0.1; its P/E ratio is -3.28; Oncolytics Biotech is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
